$CVRS: Corindus Announces FDA Submission for Neurovascular …

Date: Thursday, February 14th, 2019

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of …

Full article address: https://www.businesswire.com/news/home/20190214005152/en/Corindus-Announces-FDA-Submission-Neurovascular-Intervention-Indication

Related News:

$CVRS: Corindus Technology Successfully used in Multiple Live Complex …

Latest News:

$CAI: CAI International Inc (CAI) Q4 2018 Earnings Conference Call …

$NUVA: NuVasive, Inc. (NUVA) CEO Chris Barry on Q4 2018 Results …

$SAM: Boston Beer (SAM) Q4 2018 Earnings Conference Call Transcript

$NGQ: NGEx Reports 2018 Results

$MLP: Maui Land & Pineapple Reports 2018 Net Income of $0.6 Million

$VXRT: Vaxart files for 6M-share stock offering; shares down 2% after hours

$MESA: British airline chooses deal from Richard Branson over Mesa Air …

$PI: Impinj (PI) Q4 2018 Earnings Conference Call Transcript

$CECO: Career Education Corporation (CECO) CEO Todd Nelson on Q4 …

$CAKE: The Cheesecake Factory Incorporated (CAKE) CEO David Overton …

$WK: Workiva (WK) CEO Marty Vanderploeg on Q4 2018 Results …